In contrast to premature (and sometimes downright erroneous) mainstream media reports about quick fixes for the COVID-19 pandemic, the Food and Drug Administration and the Centers for Disease Control and Prevention have both released reliable information about progress toward corralling the outbreak. First, the FDA has issued an emergency-use authorization for a point-of-care test for emergency use in patients suspected of having COVID-19. The Xpert Xpress SARS-CoV-2 test (Cepheid) is intended for use in high- …
Read More